Metraipolis › archive › dc_97ece774e393

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy — Europe PMC PMID:41440016

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41440016
DOI
10.3390/cells14241997
License (as archived)
solo-consultazione
Archived
2026-11-07T15:18:20.403Z
SHA-256 of the archived text
c4e9ac0b17f185cfface7d62072d7ac5b0586bf248cfe5e77e8a0444cdcb907f
Stable URL of this page
https://metraipolis.com/documento/dc_97ece774e393

How to cite

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy — Europe PMC PMID:41440016 — Europe PMC (en), https://europepmc.org/article/MED/41440016 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97ece774e393 (Metraipolis archive dc_97ece774e393, sha256 c4e9ac0b17f185cfface7d62072d7ac5b0586bf248cfe5e77e8a0444cdcb907f)
BibTeX
@misc{dc97ece774e393,
  title = {Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy — Europe PMC PMID:41440016},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41440016},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97ece774e393; sha256 c4e9ac0b17f185cfface7d62072d7ac5b0586bf248cfe5e77e8a0444cdcb907f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41440016. Agents can read the archived copy with the MCP tool read_document.